Literature DB >> 34853574

Sudden Cardiac Death in the General Population: Can We Improve Risk Stratification and Prevention?

Gary L Murray1, Joseph Colombo2,3.   

Abstract

A total of 15 to 20% of deaths worldwide are sudden (within 1 hour of symptom onset). Our ability to predict and prevent sudden cardiac death (SCD) in the general population, in which 85% have no known organic heart disease (OHD) or stable OHD with left ventricular ejection fraction >40%, is limited to poor. The purpose of this commentary is to suggest a new approach to SCD in this population. Oxidative stress is a common thread in development and progression of the major cardiac diseases associated with SCD. It has a profound adverse effect upon heart rate variability (HRV), sympathetic tone (S), and parasympathetic tone (P). Recently, developed technology finally has allowed accurate measures of S and P. Using this technique, the general population can be screened, those at risk for SCD can be identified with a higher degree of success, and preventative measures instituted. For example, in 133 geriatric type 2 diabetics with S and/or P abnormalities upon screening, the potent and natural antioxidant (r)α lipoic acid reduced SCD (relative risk reduction) 43% ( p  = 0.0076), mean follow-up 6.31 years. Diabetes mellitus patients have high glycemic oxidative stress. Addressing oxidative stress S and P abnormalities can reduce SCD. S and P screening of the general population will be discussed. International College of Angiology. This article is published by Thieme.

Entities:  

Keywords:  acute myocardial infarction; diabetes; oxidative stress; prevention; sudden cardiac death; ventricular fibrillation; α lipoic acid

Year:  2021        PMID: 34853574      PMCID: PMC8608466          DOI: 10.1055/s-0041-1729629

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  27 in total

1.  Comparison of HRV analysis methods during orthostatic challenge: HRV with respiration or without?

Authors:  Benhur Aysin; Joe Colombo; Elif Aysin
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2007

2.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

3.  Hemodynamic regulation: investigation by spectral analysis.

Authors:  S Akselrod; D Gordon; J B Madwed; N C Snidman; D C Shannon; R J Cohen
Journal:  Am J Physiol       Date:  1985-10

4.  In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice.

Authors:  A Rakhit; C T Maguire; H Wakimoto; J Gehrmann; G K Li; R A Kelly; T Michel; C I Berul
Journal:  J Cardiovasc Electrophysiol       Date:  2001-11

5.  Ranolazine Therapy Reduces Non-ST-Segment-Elevation Myocardial Infarction and Unstable Angina in Coronary Disease Patients with Angina.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Int J Angiol       Date:  2016-04-28

6.  (r)Alpha Lipoic Acid Is a Safe, Effective Pharmacologic Therapy of Chronic Orthostatic Hypotension Associated with Low Sympathetic Tone.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Int J Angiol       Date:  2019-02-22

Review 7.  Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.

Authors:  Nadia Hussain; Thomas E Adrian
Journal:  Curr Diabetes Rev       Date:  2017

8.  Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study.

Authors:  Anna M Kucharska-Newton; David J Couper; James S Pankow; Ronald J Prineas; Thomas D Rea; Nona Sotoodehnia; Aravinda Chakravarti; Aaron R Folsom; David S Siscovick; Wayne D Rosamond
Journal:  Acta Diabetol       Date:  2009-10-24       Impact factor: 4.280

9.  Risk stratification for sudden cardiac death: current status and challenges for the future.

Authors:  Hein J J Wellens; Peter J Schwartz; Fred W Lindemans; Alfred E Buxton; Jeffrey J Goldberger; Stefan H Hohnloser; Heikki V Huikuri; Stefan Kääb; Maria Teresa La Rovere; Marek Malik; Robert J Myerburg; Maarten L Simoons; Karl Swedberg; Jan Tijssen; Adriaan A Voors; Arthur A Wilde
Journal:  Eur Heart J       Date:  2014-05-05       Impact factor: 29.983

10.  Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Heart Int       Date:  2014-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.